Literature DB >> 7870876

Subsensitivity to rewarding and locomotor stimulant effects of a dopamine agonist following chronic mild stress.

M Papp1, R Muscat, P Willner.   

Abstract

Chronic exposure to very mild unpredictable stress has previously been found to reduce or abolish the acquisition of place preference conditioning. In the present study, chronic mild stress was found to abolish the acquisition of preferences for a distinctive environment paired with systemic administration of amphetamine (0.5 mg/kg) or quinpirole (100-400 micrograms/kg) or with quinpirole (0.75 micrograms) administered bilaterally within the nucleus accumbens. The locomotor stimulant effects of quinpirole (100-400 micrograms/kg) were also attenuated in stressed animals. The result suggest that decreased sensitivity to reward following chronic mild stress results from a decreased sensitivity of dopamine D2 receptors within the nucleus accumbens.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 7870876     DOI: 10.1007/bf02246965

Source DB:  PubMed          Journal:  Psychopharmacology (Berl)        ISSN: 0033-3158            Impact factor:   4.530


  37 in total

1.  Attenuation of place preference conditioning but not place aversion conditioning by chronic mild stress.

Authors:  M Papp; S Lappas; R Muscat; P Willner
Journal:  J Psychopharmacol       Date:  1992-01       Impact factor: 4.153

2.  An animal model of anhedonia: attenuation of sucrose consumption and place preference conditioning by chronic unpredictable mild stress.

Authors:  M Papp; P Willner; R Muscat
Journal:  Psychopharmacology (Berl)       Date:  1991       Impact factor: 4.530

3.  The effects of psychomotor stimulants on stereotypy and locomotor activity in socially-deprived and control rats.

Authors:  B J Sahakian; T W Robbins; M J Morgan; S D Iversen
Journal:  Brain Res       Date:  1975-02-07       Impact factor: 3.252

4.  The dopamine D2 receptor agonists, quinpirole and bromocriptine produce conditioned place preferences.

Authors:  D C Hoffman; P R Dickson; R J Beninger
Journal:  Prog Neuropsychopharmacol Biol Psychiatry       Date:  1988       Impact factor: 5.067

5.  Effects of task-irrelevant cues and reinforcement delay on choice-escape learning following inescapable shock: evidence for a deficit in selective attention.

Authors:  T R Minor; R L Jackson; S F Maier
Journal:  J Exp Psychol Anim Behav Process       Date:  1984-10

6.  Life events and depressive disorder reviewed. II. Events as precipitating factors.

Authors:  C Lloyd
Journal:  Arch Gen Psychiatry       Date:  1980-05

7.  Paradoxical reinforcing properties of apomorphine: effects of nucleus accumbens and area postrema lesions.

Authors:  D van der Kooy; N R Swerdlow; G F Koob
Journal:  Brain Res       Date:  1983-01-17       Impact factor: 3.252

8.  Conditioned place preference from intra-accumbens but not intra-caudate amphetamine injections.

Authors:  G D Carr; N M White
Journal:  Life Sci       Date:  1983-12-19       Impact factor: 5.037

9.  Voltammetric evidence that subsensitivity to reward following chronic mild stress is associated with increased release of mesolimbic dopamine.

Authors:  J A Stamford; R Muscat; J J O'Connor; J Patel; S J Trout; W J Wieczorek; Z L Kruk; P Willner
Journal:  Psychopharmacology (Berl)       Date:  1991       Impact factor: 4.530

10.  Uncontrollable shock proactively increases sensitivity to response-reinforcer independence in rats.

Authors:  R A Rosellini; J P DeCola; M Plonsky; D A Warren; A J Stilman
Journal:  J Exp Psychol Anim Behav Process       Date:  1984-07
View more
  13 in total

1.  Attenuation of sucrose consumption in mice by chronic mild stress and its restoration by imipramine.

Authors:  S Monleon; P D'Aquila; A Parra; V M Simon; P F Brain; P Willner
Journal:  Psychopharmacology (Berl)       Date:  1995-02       Impact factor: 4.530

2.  Exposure to mild stress enhances the reinforcing efficacy of intravenous heroin self-administration in rats.

Authors:  Y Shaham; J Stewart
Journal:  Psychopharmacology (Berl)       Date:  1994-04       Impact factor: 4.530

3.  Behavioural sensitization to a dopamine agonist is associated with reversal of stress-induced anhedonia.

Authors:  M Papp; P Willner; R Muscat
Journal:  Psychopharmacology (Berl)       Date:  1993       Impact factor: 4.530

4.  Parallel changes in dopamine D2 receptor binding in limbic forebrain associated with chronic mild stress-induced anhedonia and its reversal by imipramine.

Authors:  M Papp; V Klimek; P Willner
Journal:  Psychopharmacology (Berl)       Date:  1994-08       Impact factor: 4.530

5.  Moderate prenatal alcohol exposure and serotonin genotype interact to alter CNS serotonin function in rhesus monkey offspring.

Authors:  Mary L Schneider; Colleen F Moore; Christina S Barr; Julie A Larson; Gary W Kraemer
Journal:  Alcohol Clin Exp Res       Date:  2011-02-05       Impact factor: 3.455

6.  Reversal of stress-induced anhedonia by the dopamine receptor agonist, pramipexole.

Authors:  P Willner; S Lappas; S Cheeta; R Muscat
Journal:  Psychopharmacology (Berl)       Date:  1994-08       Impact factor: 4.530

7.  Modeling hypohedonia following repeated social defeat: Individual vulnerability and dopaminergic involvement.

Authors:  Samantha R Spierling; Maegan Mattock; Eric P Zorrilla
Journal:  Physiol Behav       Date:  2017-04-19

8.  Stereospecific reversal of stress-induced anhedonia by mianserin and its (+)-enantiomer.

Authors:  S Cheeta; C Broekkamp; P Willner
Journal:  Psychopharmacology (Berl)       Date:  1994-12       Impact factor: 4.530

9.  Chronic unpredictable stress enhances cocaine-conditioned place preference in type 1 cannabinoid receptor knockout mice.

Authors:  Laurence L Miller; Sara J Ward; Linda A Dykstra
Journal:  Behav Pharmacol       Date:  2008-09       Impact factor: 2.293

10.  Curative effects of the atypical antidepressant mianserin in the chronic mild stress-induced anhedonia model of depression.

Authors:  J L Moreau; A Bourson; F Jenck; J R Martin; P Mortas
Journal:  J Psychiatry Neurosci       Date:  1994-01       Impact factor: 6.186

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.